Inventor · disambiguated record
Hannah Joy Edwards
Also filed as: EDWARDS HANNAH JOY
17 granted patents·12 pending applications·83 citations·filing 2012–2024
92Inventor score
Top patents by PatentIndex Score
29 records- 0191US10364238B2N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2015·Granted Jul 30, 2019·8 cites·16 claims
- 0289US10781181B2N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2015·Granted Sep 22, 2020·6 cites·36 claims
- 0389US10611758B2N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2019·Granted Apr 7, 2020·4 cites·1 claims
- 0489US10221161B2Inhibitors of plasma kallikreinKALVISTA PHARMACEUTICALS LTD·Filed 2014·Granted Mar 5, 2019·13 cites·32 claims
- 0588US9533987B2Heterocyclic derivatesKALVISTA PHARMACEUTICALS LTD·Filed 2014·Granted Jan 3, 2017·19 cites·27 claims
- 0687US2025074903A1N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein InhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 0785US9670157B2Benzylamine derivativesKALVISTA PHARMACEUTICALS LTD·Filed 2014·Granted Jun 6, 2017·13 cites·30 claims
- 0884US9738641B2Bicyclic inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2014·Granted Aug 22, 2017·13 cites·29 claims
- 0983US11230537B2Polymorphs of n-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[2-oxopyridin-1-yl)methyl]phenyl} methyl)pyrazole-4-carboxamide as iallikrein inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2017·Granted Jan 25, 2022·3 cites·11 claims
- 1079US9834513B2Benzylamine derivativesKALVISTA PHARMACEUTICALS LTD·Filed 2017·Granted Dec 5, 2017·4 cites·26 claims
- 1177US2022289729A1N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein InhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 1276US11001578B2N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2019·Granted May 11, 2021·0 cites·30 claims
- 1375US11084809B2N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2020·Granted Aug 10, 2021·0 cites·15 claims
- 1472US11739068B2Polymorphs of N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide and salts thereofKALVISTA PHARMACEUTICALS LTD·Filed 2021·Granted Aug 29, 2023·0 cites·13 claims
- 1572US11198691B2N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2020·Granted Dec 14, 2021·0 cites·24 claims
- 1670US2024199573A1Polymorphs of n-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide and salts thereofKALVISTA PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 1769US2023250080A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 1867US2022153724A1Inhibitors Of Plasma KallikreinKALVISTA PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 1964US11613527B2Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2021·Granted Mar 28, 2023·0 cites·46 claims
- 2063US2022002275A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 2161US11242333B2Inhibitors of plasma kallikreinKALVISTA PHARMACEUTICALS LTD·Filed 2019·Granted Feb 8, 2022·0 cites·15 claims
- 2254US2024059691A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 2353US2024327412A1Factor xiia inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 2448US2022289727A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 2546US9051249B2Benzylamine derivatives as inhibitors of plasma kallikreinEVANS DAVID MICHAEL·Filed 2012·Granted Jun 9, 2015·0 cites·17 claims
- 2646US2022363668A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 2743US2022298138A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 2843US2022298141A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 2941US9234000B2Benzylamine derivatives as inhibitors of plasma kallikreinKALVISTA PHARMACEUTICALS LTD·Filed 2015·Granted Jan 12, 2016·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →